Healthcare Triangle (HCTI) Stock Price

Healthcare Triangle Price

NYSE·CLOSED
0.69
​
Market closed

Revenue at Healthcare Triangle has contracted by 16.5% per year over the past 5 years to 11.70 M USD. For Healthcare Triangle, the net margin of -51.0% is down versus 7.5% a few years ago. The consensus 12-month price target for Healthcare Triangle is 1.53 USD, about 121.8% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Healthcare Triangle stock price

Access this data via the Eulerpool API

Healthcare Triangle business model & stock analysis

Healthcare Triangle, Inc. operates as a healthcare information technology company, which engages in advancing various solutions for the cloud services, data science, and professional and managed services sectors for the healthcare and life sciences industry. The company is headquartered in Pleasanton, California and currently employs 47 full-time employees. The company went IPO on 2021-10-01. The firm is focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record (EHR), healthcare and life sciences industries. Through its platform, solutions, and services, the Company supports healthcare delivery organizations, healthcare insurance companies, pharmaceutical and Life Sciences, biotech companies, and medical device manufacturers in their efforts to improve data management, develop analytical insights into their operations, and deliver measurable clinical, financial, and operational improvements. The firm's software platforms, CloudEz and DataEz, are leveraged by its healthcare and life sciences customers for cloud transformation, automation, data management, security and data governance, and clinical and non-clinical operations management.

Frequently asked questions about Healthcare Triangle

Analysts currently set an average price target of 1.53 USD for the Healthcare Triangle stock (median: 1.53 USD), implying +121.8 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Healthcare Triangle stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Healthcare Triangle to generate revenue of 24.91 M USD and earnings per share of -54.06 USD.

Converted at the current exchange rate, the Healthcare Triangle share trades at 0.61 EUR (0.69 USD).

The expected revenue of Healthcare Triangle is 24.91 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Healthcare Triangle is -21,624.00 USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Healthcare Triangle is currently -0.01. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Healthcare Triangle stock.

The price-to-sales ratio (P/S) of Healthcare Triangle is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Healthcare Triangle stock.

The Eulerpool Quality Score for Healthcare Triangle is 1/10.

The ISIN of Healthcare Triangle is US42227W4050. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Healthcare Triangle is A3EG3C. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Healthcare Triangle is HCTI. The ticker symbol is used to trade Healthcare Triangle shares on the stock exchange.

Fair ValueTerminal
0.58 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
248,851.06 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Oct 1, 2021
ISIN
US42227W4050
Cusip
42227W207
Market capitalization
275.96 USDMicro Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee 2025
-0.00
P/Ee 2026
-0.01
P/Ee 2027
-0.03
P/Ee 2028
3.38
P/S
P/Se
0.00
EV/EBIT
—
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
242.25 %
Gross Margin
24.71 %
EBIT Margin
-40.62 %
Net Margin
-51.03 %
EPS (Earnings Per Share)
-14,922.50 USD
Net Debt / EBIT
-0.55
Debt/Equity
-0.52
Last updated Oct 1, 2026, 1:21 PM

Healthcare Triangle Peer Group